FAsenra Safety Trial in India
NCT05384938
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
139
Enrollment
INDUSTRY
Sponsor class
Conditions
In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India
Interventions
BIOLOGICAL:
Benralizumab
Sponsor
AstraZeneca